Literature DB >> 31190195

Hypertension and Health-Related Quality of Life (HRQoL): Evidence from the US Hispanic Population.

Elizabeth Riley1, Jongwha Chang2, Chanhyun Park3, Sean Kim4, Inho Song5.   

Abstract

BACKGROUND AND
OBJECTIVE: Little evidence exists regarding the marginal decrease in health-related quality of life (HRQoL) in relation to the presence of hypertension among a Hispanic population based on US population-based research.
METHOD: This cross-sectional study used data from the 2014 to 2015 Medical Expenditure Panel Survey (MEPS). The target population was comprised of Hispanic community-dwelling residents with hypertension in the USA. The independent variable was the presence of hypertension. The dependent variable was HRQoL, which was measured using the Short Form-12 (SF-12) physical health composite scale (PCS) and mental health composite scale (MCS).
RESULTS: A total of 13,933 members of the Hispanic population met the study inclusion criteria, and the estimated population size was 36,440,400 Hispanics. Among them, 82.9% did not have any hypertensive condition (n = 11,466), while 17.7% had some hypertensive condition (n = 2467). SF-12 PCS scores (95% CI) were 46.62 (45.68-47.57) in the Hispanic population with hypertension and 51.62 (51.1-52.14) in the Hispanic population without hypertension. SF-12 MCS scores (95% CI) were 52.67 (52.07-53.27) in patients without hypertension and 50.35 (49.45-51.26) in the Hispanic population with hypertensive conditions.
CONCLUSION: The presence of hypertension was associated with lower HRQoL in the Hispanic population. Based on our findings, we suggest that healthcare providers should monitor a hypertensive minority population for anxiety and mood disorders and recommend psychiatric assessment and treatment if appropriate.

Entities:  

Mesh:

Year:  2019        PMID: 31190195     DOI: 10.1007/s40261-019-00814-4

Source DB:  PubMed          Journal:  Clin Drug Investig        ISSN: 1173-2563            Impact factor:   2.859


  29 in total

1.  The SF-12 as a population health measure: an exploratory examination of potential for application.

Authors:  J N Burdine; M R Felix; A L Abel; C J Wiltraut; Y J Musselman
Journal:  Health Serv Res       Date:  2000-10       Impact factor: 3.402

Review 2.  Design strategies and innovations in the medical expenditure panel survey.

Authors:  Steven B Cohen
Journal:  Med Care       Date:  2003-07       Impact factor: 2.983

3.  Health-related quality of life and hypertension status, awareness, treatment, and control: National Health and Nutrition Examination Survey, 2001--2004.

Authors:  Donald K Hayes; Clark H Denny; Nora L Keenan; Janet B Croft; Kurt J Greenlund
Journal:  J Hypertens       Date:  2008-04       Impact factor: 4.844

Review 4.  Treatment and blood pressure control in 47,964 people with diabetes and hypertension: a systematic review of observational studies.

Authors:  Donna L McLean; Scot H Simpson; Finlay A McAlister; Ross T Tsuyuki
Journal:  Can J Cardiol       Date:  2006-08       Impact factor: 5.223

Review 5.  Health disparities in the Latino population.

Authors:  William A Vega; Michael A Rodriguez; Elisabeth Gruskin
Journal:  Epidemiol Rev       Date:  2009-08-27       Impact factor: 6.222

6.  Reliability and validity of the SF-12v2 in the medical expenditure panel survey.

Authors:  Nancy C Cheak-Zamora; Kathleen W Wyrwich; Timothy D McBride
Journal:  Qual Life Res       Date:  2009-05-08       Impact factor: 4.147

7.  Risk-factor clustering and cardiovascular disease risk in hypertensive patients.

Authors:  Derek Weycker; Gregory A Nichols; Maureen O'Keeffe-Rosetti; John Edelsberg; Zeba M Khan; Satyin Kaura; Gerry Oster
Journal:  Am J Hypertens       Date:  2007-06       Impact factor: 2.689

8.  Health-related quality of life and blood pressure control in hypertensive patients with and without complications.

Authors:  Josiane Lima de Gusmão; Decio Mion; Angela Maria Geraldo Pierin
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

Review 9.  Blood pressure control in patients with comorbidities.

Authors:  Roland E Schmieder; Luis M Ruilope
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-08       Impact factor: 3.738

Review 10.  Multimorbidity and quality of life in primary care: a systematic review.

Authors:  Martin Fortin; Lise Lapointe; Catherine Hudon; Alain Vanasse; Antoine L Ntetu; Danielle Maltais
Journal:  Health Qual Life Outcomes       Date:  2004-09-20       Impact factor: 3.186

View more
  5 in total

1.  Association between comorbidity and health-related quality of life in a hypertensive population: a hospital-based study in Bangladesh.

Authors:  Adnan Mannan; Kazi Mahmuda Akter; Farhana Akter; Naim Uddin Hasan A Chy; Nazmul Alam; Susmita Dey Pinky; Abul Faisal Md Nuruddin Chowdhury; Parijat Biswas; Afrin Sultana Chowdhury; Mohammed Akram Hossain; Md Mashud Rana
Journal:  BMC Public Health       Date:  2022-01-26       Impact factor: 3.295

2.  Association between dietary acid load and clinical features of migraine headaches among Iranian individuals.

Authors:  Keyhan Lotfi; Gholamreza Askari; Hamed Mohammad; Abdulmannan Fadel; Fariborz Khorvash; Arman Arab
Journal:  Sci Rep       Date:  2022-02-14       Impact factor: 4.379

3.  The effect of high blood pressure-health literacy, self-management behavior, self-efficacy and social support on the health-related quality of life of Kazakh hypertension patients in a low-income rural area of China: a structural equation model.

Authors:  Qinghua Zhang; Feifei Huang; Lei Zhang; Shasha Li; Jingping Zhang
Journal:  BMC Public Health       Date:  2021-06-10       Impact factor: 3.295

4.  Quality of Life of Patients with Arterial Hypertension.

Authors:  Katarzyna Snarska; Monika Chorąży; Michał Szczepański; Marzena Wojewódzka-Żelezniakowicz; Jerzy Robert Ładny
Journal:  Medicina (Kaunas)       Date:  2020-09-09       Impact factor: 2.430

5.  Reference data among general population and known-groups validity among hypertensive population of the EQ-5D-5L in Vietnam.

Authors:  Vu Quynh Mai; Kim Bao Giang; Hoang Van Minh; Lars Lindholm; Sun Sun; Klas Göran Sahlen
Journal:  Qual Life Res       Date:  2021-08-09       Impact factor: 4.147

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.